Cite
MLA Citation
M. Tobiasson et al.. “S167: PREDICTION OF RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION USING INDIVIDUALIZED MEASURABLE RESIDUAL DISEASE MARKERS; THE PROSPECTIVE NORDIC STUDY NMDSG14B.” HemaSphere, vol. 6, n.d., pp. 68–69. http://access.bl.uk/ark:/81055/vdc_100158013878.0x00002d